Metabolite-based dietary supplementation in human type 1 diabetes is associated with microbiota and immune modulation.

Kirstine J BellSonia SaadBree J TillettHelen M McGuireSara BordbarYu Anne YapLong T NguyenMarc R WilkinsSusan CorleyShannon BrodieSussan DuongCourtney J WrightStephen TwiggBarbara Fazekas de St GrothLeonard C HarrisonCharles R MackayEsteban N GurzovEmma E Hamilton-WilliamsEliana Mariño

Published in: Microbiome (2022)

ACTRN12618001391268. Registered 20 August 2018, https://www.anzctr.org.au/Trial/Registration/TrialReview.aspx?id=375792 Video Abstract.

Keyphrases

type diabetes
endothelial cells
study protocol
clinical trial
induced pluripotent stem cells
cardiovascular disease
pluripotent stem cells
glycemic control
insulin resistance
randomized controlled trial
reduced graphene oxide
metabolic syndrome
adipose tissue
skeletal muscle
weight loss